AMENDMENT TO 4% UNSECURED PROMISSORY NOTEVitro Biopharma, Inc. • February 2nd, 2024 • Biological products, (no disgnostic substances) • Colorado
Company FiledFebruary 2nd, 2024 Industry JurisdictionTHIS AMENDMENT TO 4% UNSECURED PROMISSORY NOTE (this “Amendment”) is entered into and made effective as of January, 31, 2024 (the “Effective Date”), by and between VITRO BIOPHARMA, INC., a Nevada corporation (the “Company”), and JIM MUSICK, an individual (the “Holder”).
CONSULTING AGREEMENTConsulting Agreement • February 2nd, 2024 • Vitro Biopharma, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 2nd, 2024 Company Industry JurisdictionThis Consulting Agreement (this “Agreement”) is entered into as of this 16th day of November, 2023 (the “Effective Date”), by and between (1) Alchemy Advisory LLC, a limited liability company organized under the laws of Puerto Rico (the “Consultant”) and located at 144 Hillside Village, Rio Grande, PR 00745, and (2) Vitro Biopharma, Inc., a Nevada corporation (the “Company”) and having its principal place of business at 3200 Cherry Creek Drive South, Suite 720, Denver, Colorado 80209. The Company and Consultant are collectively referred to herein as the “Parties”.